Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.
|Vol / Avg.1.004M / 485.990K||Mkt Cap4.146B|
|Day Range194.884 - 227.940||52 Wk Range57.220 - 322.670|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-14||JMP Securities||Jonathan Wolleben||Reiterates||Market OutperformMarket Outperform||Maintains||-||383.00|
|2023-11-13||HC Wainwright & Co.||Ed Arce||Maintains||BuyBuy||Raises||225.00||275.00|
|2023-09-19||Evercore ISI Group||Liisa Bayko||Maintains||OutperformOutperform||Maintains||325.00||325.00|
|2023-09-14||HC Wainwright & Co.||Ed Arce||Reiterates||BuyBuy||Maintains||-||225.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) through any online brokerage.
The latest price target for Madrigal Pharmaceuticals (NASDAQ: MDGL) was reported by JMP Securities on Tuesday, November 14, 2023. The analyst firm set a price target for 383.00 expecting MDGL to rise to within 12 months (a possible 82.38% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $210 last updated December 9, 2023 at 12:20 AM UTC.
There is no dividend information for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 22, 2024.
There is no upcoming split for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.